Article Details
Retrieved on: 2024-10-29 17:14:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The open-label, single-arm, multi-center, long-term, phase 3 ECZTEND (ClinicalTrials.gov Identifier: NCT03587805) extension trial evaluated the safety ...
Article found on: www.dermatologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here